STOCK TITAN
  1. Home
  2. Sec-filings
  3. THAR
  4. [EFFECT] Tharimmune, Inc. SEC Filing

[EFFECT] Tharimmune, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 5:00 P.M.
Form: S-3
CIK: 0001861657
Company Name: Tharimmune, Inc.
File Number: 333-288518

Source: View Original Filing on SEC EDGAR

Stock THAR logo
Tharimmune Inc

NASDAQ:THAR

THAR Rankings

#4906 Ranked by Market Cap
N/A Ranked by Dividends

THAR Latest News

Jan 26, 2026
Tharimmune Announces Expanded Role as Super Validator on Canton Network
Jan 22, 2026
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
Jan 20, 2026
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
Dec 18, 2025
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network
Dec 12, 2025
Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

THAR Latest SEC Filings

Jan 26, 2026
[8-K] Tharimmune, Inc. Reports Material Event
Jan 22, 2026
[8-K] Tharimmune, Inc. Reports Material Event
Jan 21, 2026
[SCHEDULE 13G/A] Tharimmune, Inc. Amended Passive Investment Disclosure
Jan 20, 2026
[8-K] Tharimmune, Inc. Reports Material Event
Jan 20, 2026
[424B5] Tharimmune, Inc. Prospectus Supplement (Debt Securities)

THAR Stock Data

118.98M
53.96M
17.13%
1.5%
12.08%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER